Literature DB >> 7257024

Partial rat kidney resection using autologous fibrinogen thrombin adhesive system.

H Pflüger, W Stackl, D Kerjaschki, M Weissel.   

Abstract

The Fibrinogen Thrombin Adhesive System (FTAS) enables local haemostasis to occur in parenchymatous organs without tissue damage. The aim of this study was to investigate the degradation of FTAS and the process of wound healing after partial kidney resection in rats using FTAS for induction of local haemostasis. In 28 rats partial kidney resection was performed bilaterally. Haemostasis was achieved with Fibrinogen Thrombin Adhesive System. Four experimental groups were formed. Group A (n = 3): Haemostasis with unlabelled FTAS, subcutaneous injection of 0.1 ml = 60 mu Ci Na 125I. Group B (n = 3): Haemostasis with unlabelled FTAS, subcutaneous injection of 0.1 ml = 60 mu Ci 125I FTAS. Group C (n = 6): Haemostasis with 125I labelled FTAS. Group D (n = 16): treated like Group C. In Groups A - C 125I-elimination in 24 h urine samples was determined with a gamma-scintillation counter. Pairs of animals in Group D were killed after 2, 6, 12 and 24 h and 3, 7, 14 and 21 days. Kidneys were examined under the light and electron microscope and by autoradiography. In animals of Groups B and C two peaks of 125I excretion were observed: one peak within the first 48 h postoperatively which corresponded to the amount of free iodine injected with FTAS (FTAS contains 15% free iodine); a second peak after 120 h which was most probably due to the degradation of FTAS. Fibrinolysis was not observed. FTAS was resorbed mainly by macrophages. The time course of wound healing paralleled that of physiological fibrinogen concentration. Renal parenchymal damage was not observed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7257024     DOI: 10.1007/bf00254403

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  8 in total

1.  [Anastomosis of the vas deferens employing concentrated fibrinogen: an experimental study in rabbits (authors transl)].

Authors:  H Pflüger; G Lunglmayr; G Breitenecker
Journal:  Wien Klin Wochenschr       Date:  1976-12-24       Impact factor: 1.704

2.  [EXPERIMENTAL RESULTS OF CLOSURE OF KIDNEY PARENCHYMA WOUNDS WITHOUT SUTURES].

Authors:  F TRUSS; K H THIEL
Journal:  Urologe       Date:  1965-05       Impact factor: 0.639

3.  The mechanism of clot dissolution by plasmin.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

4.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

5.  [Tissue adhesion and local haemostasis using fibrinogen, thrombin and clotting factor xiii. (experimental investigations--clinical experience) (author's transl)].

Authors:  H P Spängler
Journal:  Wien Klin Wochenschr Suppl       Date:  1976

6.  [The action of high-concentrated fibria on bone healing (author's transl)].

Authors:  P Bösch; F Braun; J Eschberger; W Kovac; H P Spängler
Journal:  Arch Orthop Unfallchir       Date:  1977-09-29

7.  The influence of different fixatives and fixation methods on the ultrastructure of rat kidney proximal tubule cells. I. Comparison of different perfusion fixation methods and of glutaraldehyde, formaldehyde and osmium tetroxide fixatives.

Authors:  A B Maunsbach
Journal:  J Ultrastruct Res       Date:  1966-06

8.  [Experiences with a biological adhesive system (fibrin) in the dressing of kidney parenchymal wounds (animal experiment and 1st clinical experiences)].

Authors:  F Braun; K Henning; J Holle; W Kovac; K Rauchenwald; H P Spängler; H Urlesberger
Journal:  Zentralbl Chir       Date:  1977       Impact factor: 0.942

  8 in total
  1 in total

1.  Evaluation of fibrin sealant for biologic mesh fixation at the hiatus in a porcine model.

Authors:  David M Krpata; Jeffrey A Blatnik; Karem C Harth; Melissa S Phillips; Yuri W Novitsky; Michael J Rosen
Journal:  Surg Endosc       Date:  2012-04-27       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.